# Io Health Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/io-health-technologies

- Industry: Healthcare IT
- Headquarters: Pasadena, US
- Website: www.iohealth.ai/
- Total disclosed funding: $2M
- Latest round: Seed (Oct 7, 2025)
- Investors on record: 1

## About

Io Health Technologies, LLC, based in the US, specializes in AI-driven home health technology solutions that optimize operational efficiency and improve documentation accuracy for home health agencies.Founded in 2023, Io Health Technologies, LLC provides innovative technology solutions for home health agencies. In October 2025, Io Health Technologies, LLC raised USD 2 million in seed funding led by investor Nina Capital. As of November 2025, the company is led by CEO David A. Bell. ioHealth specializes in AI-driven home health technology solutions, primarily designed to enhance operational efficiency and documentation accuracy for home health agencies. The company's flagship products, including ioAssist™ and ioDoc™, provide real-time guidance for clinicians, optimizing the OASIS documentation process and reducing the workload associated with quality assurance (QA). These solutions are built to integrate seamlessly into existing electronic medical records (EMR) systems without requiring additional training, thereby minimizing disruptions in workflow. ioHealth's client base includes home health agencies operating across various states in the U.S., focusing on improving revenue capture and clinician confidence through data-driven insights. The technology addresses critical challenges in home health care, such as reducing documentation errors, accelerating cash flow, and enhancing patient outcomes.Revenue generation for ioHealth is primarily based on a subscription model, where agencies pay for access to the software solutions that enhance their documentation processes and QA efforts. Clients typically enter into agreements for these services, which may include tiered pricing plans based on the scale of their operations and the specific features utilized. For example, agencies might subscribe to ioHealth’s services to reduce OASIS errors and improve documentation efficiency, subsequently benefiting from measurable revenue increases per episode. The company’s partnerships with healthcare agencies facilitate a B2B transaction structure, where ioHealth’s technology directly supports the operational needs of its clients and improves their financial performance. Through these transactions, ioHealth enables agencies to streamline their workflows, ultimately leading to quicker reimbursements and enhanced service delivery.In October 2025, Io Health Technologies, LLC raised USD 2.00 mn in Seed funding led by new investor Nina Capital. The company plans to utilize this funding to enhance its technology and the quality of its platform. Future initiatives include the development of new products aimed at expanding into additional geographic markets, although specific regions and product details have not been disclosed.

## Funding rounds

- Seed, Oct 7, 2025, $2M — Nina Capital

## Investors

- Nina Capital (https://capitalatlas.ai/funds/nina-capital) — Seed